IP Library Granted Patent US 8,142,364
Granted Patent B2
US 8,142,364 · App. 12/651,929 · Granted Mar 27, 2012

Method of monitoring intraocular pressure and treating an ocular disorder

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,142,364
App. No.
12/651,929
Granted
Mar 27, 2012
Kind
B2
Abstract

The invention discloses a trabecular stent and methods for treating glaucoma. The stent may incorporate an intraocular pressure sensor comprising a compressible element that is implanted inside an anterior chamber of an eye, wherein at least one external dimension of the element correlates with intraocular pressure. In some embodiments, the sensor may be coupled to the stent. Also disclosed are methods of delivery of the stent and the sensor to the eye.

Claims (43)

1. A method of determining intraocular pressure, comprising:

providing a delivery device having a size of at least 20 gauge, the delivery device including a lumen extending through at least a portion thereof;

providing a sensor element configured to determine intraocular pressure and being held in the lumen of the delivery device;

forming an incision to access an anterior chamber of an eye;

inserting the delivery device through the incision into the anterior chamber of the eye;

advancing the sensor element, using the delivery device, from within the anterior chamber to eye tissue;

anchoring the sensor element to the eye tissue to determine the intraocular pressure of the eye with the sensor element being positioned completely within the anterior chamber and being exposed to aqueous humor; and

exposing the anterior chamber to a drug.

2. The method of claim 1 additionally comprising providing an implant held within the lumen of the delivery device.

3. The method of claim 2 additionally comprising positioning at least a portion of the implant in ocular tissue using the delivery device.

4. The method of claim 2 additionally comprising serially delivering the sensor element and the implant into the eye.

5. The method of claim 1 , wherein anchoring the sensor element to the eye tissue comprises anchoring the sensor element to an iris of the eye.

6. The method of claim 1 , wherein providing a delivery device having a size of at least 20 gauge comprises providing the delivery device with a size in the range from about 20 gauge to about 40 gauge.

7. The method of claim 1 , wherein forming an incision comprises forming the incision with a sufficiently small size such that the incision is self-sealing.

8. The method of claim 1 additionally comprising positioning an implant within the eye.

9. The method of claim 8 , wherein exposing the anterior chamber to a drug comprises eluting the drug from the implant.

10. The method of claim 8 additionally comprising providing the implant with a first portion and a second portion that is appended from the first portion, wherein the first portion includes a lumen and the second portion carries the drug.

11. The method of claim 8 additionally comprising providing the drug as a coating on at least a portion of the implant.

12. The method of claim 8 additionally comprising providing the drug as a coating on a biocompatible body of the implant.

13. The method of claim 8 additionally comprising providing the delivery device with at least one of the sensor element and the implant pre-loaded therein.

14. The method of claim 8 additionally comprising inserting the implant through the incision in the eye.

15. The method of claim 8 additionally comprising positioning the implant and the sensor element substantially simultaneously.

16. The method of claim 8 additionally comprising providing the sensor element in or on the implant.

17. The method of claim 8 , wherein positioning an implant comprises positioning the implant in the eye such that a distal end portion of the implant extends through ocular tissue and a proximal end portion of the implant is disposed within the anterior chamber.

18. The method of claim 8 additionally comprising conducting aqueous humor through the implant from the anterior chamber to a physiologic outflow pathway of the eye.

19. The method of claim 8 , wherein positioning an implant comprises positioning the implant in the eye such that a distal end portion of the implant is disposed in a physiologic outflow pathway of the eye and a proximal end portion of the implant is disposed within the anterior chamber.

20. The method of claim 19 additionally comprising positioning the distal end portion of the implant in Schlemm's canal.

21. The method of claim 1 , wherein forming an incision comprises forming the incision in a cornea of the eye.

22. The method of claim 1 , wherein forming an incision comprises forming the incision proximate to a limbal area of the eye.

23. The method of claim 1 additionally comprising measuring intraocular pressure.

24. A method of determining intraocular pressure, comprising:

providing a delivery device configured to be insertable into an anterior chamber of an eye;

providing an implant coupled to a sensor and being held by the delivery device;

forming an opening to access the anterior chamber;

advancing the delivery device through the opening into the anterior chamber;

transporting the implant and sensor through a portion of the anterior chamber using the delivery device; and

anchoring the implant to eye tissue from within the anterior chamber such that at least a portion of the sensor is positioned in the anterior chamber so as to be used for determining intraocular pressure.

25. The method of claim 24 additionally comprising measuring intraocular pressure.

26. The method of claim 24 , wherein forming an opening comprises forming the opening in a cornea of the eye or forming the opening proximate to a limbal area of the eye.

27. The method of claim 24 , wherein the sensor comprises a compressible element or compressible chamber.

28. The method of claim 24 additionally comprising transmitting intraocular pressure data to a receiver.

29. The method of claim 28 , wherein transmitting intraocular pressure comprises transmitting the intraocular pressure wirelessly to the receiver.

30. The method of claim 24 additionally comprising exposing the sensor to aqueous humor.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2017
From: DOSE MEDICAL CORPORATION
To: GLAUKOS CORPORATION
Reel/Frame 042251/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2014
From: HAFFNER, DAVID S.; TU, HOSHENG; GHARIB, MORTEZA
To: GLAUKOS CORPORATION
Reel/Frame 032933/0758 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2014
From: HAFFNER, DAVID; TU, ROGER (HOSHENG); MORTEZA, GHARIB
To: GLAUKOS CORPORATION
Reel/Frame 032917/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2012
From: GLAUKOS CORPORATION
To: DOSE MEDICAL CORPORATION
Reel/Frame 028808/0509 →